c‑Jun N‑terminal kinase/transforming growth factor‑β/Smad3 pathway: Is it associated with endoplasmic reticulum stress‑mediated renal interstitial fibrosis?

Liu,Yuyuan; Shen,Ping; Zhou,Yongmei; Tang,Li; Chai,Huaqi

doi:10.3892/mmr.2019.10276

c‑Jun N‑terminal kinase/transforming growth factor‑β/Smad3 pathway: Is it associated with endoplasmic reticulum stress‑mediated renal interstitial fibrosis?

Authors:
- Yuyuan Liu
- Ping Shen
- Yongmei Zhou
- Li Tang
- Huaqi Chai
View Affiliations

Affiliations: Department of Nephrology, Suzhou Municipal Hospital, Suzhou, Jiangsu 215002, P.R. China
Published online on: May 22, 2019 https://doi.org/10.3892/mmr.2019.10276
Pages: 755-762

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the role of the c‑Jun N‑terminal kinase (JNK)/transforming growth factor‑β (TGF‑β)/Smad3 pathway in endoplasmic reticulum stress (ERS)‑mediated renal interstitial fibrosis, which would be beneficial for chronic kidney disease (CKD) therapy. In human renal biopsy tissue, the expression levels of glucose‑regulated protein 78 (GRP78) and phosphorylated (p)‑JNK were examined by immunohistochemical analysis. In renal tubular HK‑2 cells, tunicamycin (TM) was used to induce ERS, and the cells were then treated with the chemical ERS inhibitor 4‑phenylbutyrate (4‑PBA) or the chemical JNK pathway inhibitor SP600125, respectively. Western blotting was then performed in the cells to determine the expression levels of GRP78 and p‑JNK proteins, as well as TGF‑β/Smad3 pathway‑associated proteins, including TGF‑β1, p‑Smad3, connective tissue growth factor and α‑smooth muscle actin. The results revealed that GRP78 and p‑JNK were evidently expressed in the renal tissues of patients with CKD, and these expression levels were significantly higher in renal tissues with severe interstitial fibrosis compared with glomerular minor lesion tissues (P<0.01 and P<0.05, respectively). Furthermore, ERS and JNK pathway inhibition decreased the expression levels of TGF‑β/Smad3 pathway signals in cells incubated with TM. ERS pathway inhibition also attenuated the expression levels of p‑JNK in HK‑2 cells. In conclusion, ERS was observed to serve an important role in the pathogenesis of CKD and may induce renal interstitial fibrosis via the JNK/TGF‑β/Smad3 pathway.

View Figures

View References

1	Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY and Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet. 382:260–272. 2013. View Article : Google Scholar : PubMed/NCBI
2	Collister D, Ferguson T, Komenda P and Tangri N: The patterns, risk factors, and prediction of progression in chronic kidney disease: A narrative review. Semin Nephrol. 36:273–282. 2016. View Article : Google Scholar : PubMed/NCBI
3	Boor P, Ostendorf T and Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 6:643–656. 2010. View Article : Google Scholar : PubMed/NCBI
4	Chiang CK, Hsu SP, Wu CT, Huang JW, Cheng HT, Chang YW, Hung KY, Wu KD and Liu SH: Endoplasmic reticulum stress implicated in the development of renal fibrosis. Mol Med. 17:1295–1305. 2011. View Article : Google Scholar : PubMed/NCBI
5	Piret SE, Olinger E, Reed AAC, Nesbit MA, Hough TA, Bentley L, Devuyst O, Cox RD and Thakker RV: A mouse model for inherited renal fibrosis associated with endoplasmic reticulum stress. Dis Model Mech. 10:773–786. 2017. View Article : Google Scholar : PubMed/NCBI
6	Ke B, Zhu N, Luo F, Xu Y and Fang X: Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review). Mol Med Rep. 16:1014–1020. 2017. View Article : Google Scholar : PubMed/NCBI
7	Dickhout JG and Krepinsky JC: Endoplasmic reticulum stress and renal disease. Antioxid Redox Signal. 11:2341–2352. 2009. View Article : Google Scholar : PubMed/NCBI
8	Inagi R, Ishimoto Y and Nangaku M: Proteostasis in endoplasmic reticulum-new mechanisms in kidney disease. Nat Rev Nephrol. 10:369–378. 2014. View Article : Google Scholar : PubMed/NCBI
9	Lee H, Noh JY, Oh Y, Kim Y, Chang JW, Chung CW, Lee ST, Kim M, Ryu H and Jung YK: IRE1 plays an essential role in ER stress-mediated aggregation of mutant hunting in via the inhibition of autophagy flux. Hum Mol Genet. 21:101–114. 2012. View Article : Google Scholar : PubMed/NCBI
10	Zheng QY, Li PP, Jin FS, Yao C, Zhang GH, Zang T and Ai X: Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. Cell Signal. 25:206–213. 2013. View Article : Google Scholar : PubMed/NCBI
11	Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
12	Hocevar BA, Brown TL and Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1345–1356. 1999. View Article : Google Scholar : PubMed/NCBI
13	Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T and Mori M: C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol. 28:754–761. 2003. View Article : Google Scholar : PubMed/NCBI
14	Ma FY, Flanc RS, Tesch GH, Han Y, Atkins RC, Bennett BL, Friedman GC, Fan JH and Nikolic-Paterson DJ: A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol. 18:472–484. 2007. View Article : Google Scholar : PubMed/NCBI
15	Liu Q, Mao H, Nie J, Chen W, Yang Q, Dong X and Yu X: Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int. 3 (Suppl 28):S88–S95. 2008.
16	Liu SH, Yang CC, Chan DC, Wu CT, Chen LP, Huang JW, Hung KY and Chiang CK: Chemical chaperon 4-phenylbutyrate protects against the endoplasmic reticulum stress-mediated renal fibrosis in vivo and in vitro. Oncotarget. 7:22116–22127. 2016.PubMed/NCBI
17	National Kidney Foundation: K/DOQI clinical practice guidelinesfor chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 39 (Suppl 1):S1–S266. 2002.PubMed/NCBI
18	Churg J, Bernstein J and Glassock RJ: Renal Disease: Classification and atlas of glomerular diseases. 2nd. Igaku-Shoin Ltd.; Tokyo: 1995
19	Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612. 2009. View Article : Google Scholar : PubMed/NCBI
20	Chang JW, Kim H, Baek CH, Lee RB, Yang WS and Lee SK: Up-regulation of SIRT1 reduces endoplasmic reticulum stress and renal fibrosis. Nephron. 133:116–128. 2016. View Article : Google Scholar : PubMed/NCBI
21	Zhu S, Wang Y, Jin J, Guan C, Li M, Xi C, Ouyang Z, Chen M, Qiu Y, Huang M and Huang Z: Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells. Toxicol In Vitro. 26:663–671. 2012. View Article : Google Scholar : PubMed/NCBI
22	Hirai Y, Iyoda M, Shibata T, Kuno Y, Kawaguchi M, Hizawa N, Matsumoto K, Wada Y, Kokubu F and Akizawa T: IL-17A stimulates granulocyte colony-stimulating factor production via ERK1/2 but not p38 or JNK in human renal proximal tubular epithelial cells. Am J Physiol Renal Physiol. 302:F244–F250. 2012. View Article : Google Scholar : PubMed/NCBI
23	Hewitson TD: Renal tubulointerstitial fibrosis: Common but never simple. Am J Physiol Renal Physiol. 296:F1239–F1244. 2009. View Article : Google Scholar : PubMed/NCBI
24	Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, et al: Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 4:42011. View Article : Google Scholar : PubMed/NCBI
25	Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM and Tang MJ: Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol. 177:1743–1754. 2010. View Article : Google Scholar : PubMed/NCBI
26	Meng XM, Huang XR, Xiao J, Chung AC, Qin W, Chen HY and Lan HY: Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int. 81:266–279. 2012. View Article : Google Scholar : PubMed/NCBI
27	Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011. View Article : Google Scholar : PubMed/NCBI
28	Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP and Lan HY: Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol. 21:1477–1487. 2010. View Article : Google Scholar : PubMed/NCBI
29	Grotendorst GR: Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8:171–179. 1997. View Article : Google Scholar : PubMed/NCBI
30	Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka I and Nakao K: Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: A potential target for preventing renal fibrosis. Am J Kidney Dis 38 (4 Suppl 1). S134–S138. 2001. View Article : Google Scholar
31	Grande MT and Lopez-Novoa JM: Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol. 5:319–328. 2009. View Article : Google Scholar : PubMed/NCBI
32	Zhao X, Fu J, Xu A, Yu L, Zhu J, Dai R, Su B, Luo T, Li N, Qin W, et al: Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis. 6:e17512015. View Article : Google Scholar : PubMed/NCBI
33	Bulut G, Kurdoglu Z, Dönmez YB, Kurdoglu M and Erten R: Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome. Int J Clin Exp Pathol. 8:8774–8785. 2015.PubMed/NCBI